Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Associations Between Endometriosis and Gut Microbiota

In a Swedish cohort, women with endometriosis had lower overall gut microbial diversity than matched controls, and 12 bacterial genera across five classes differed in abundance, though within-cohort differences by disease site or treatment disappeared after correction for multiple testing.

2026-07-05

Tumor microbiome diversity influences papillary thyroid cancer invasion

In tumors from 80 papillary thyroid cancer patients, intratumor bacterial diversity was higher in advanced T3/T4 lesions than mild T1/T2 lesions. An eight-genus bacterial signature predicted invasion status with an AUC of 0.83, and specific genera correlated with thyroid hormones and autoimmune antibodies.

2026-07-05

Tumour-associated and non-tumour-associated microbiota in colorectal cancer

In 59 colorectal cancer patients, tumour-associated microbiota differed from that of controls throughout the colon, not just on the tumour. Patients split into groups defined by bacterial co-abundance clusters, including a Pathogen Cluster of likely oral bacteria tied to inflammatory gene expression such as IL-17a.